Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001520262-25-000006
Filing Date
2025-10-10
Accepted
2025-10-10 16:41:40
Documents
1
Period of Report
2025-10-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 6027
  Complete submission text file 0001520262-25-000006.txt   7671
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Issuer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ALDEYRA THERAPEUTICS, INC. 131 HARTWELL AVENUE, SUITE 320 LEXINGTON MA 02421
Business Address
Reed Joshua (Reporting) CIK: 0001746541 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35299 | Film No.: 251388509